NASDAQ:PSTI
Delisted
Pluristem Therapeutics Stock News
$0.85
+0 (+0%)
At Close: Nov 04, 2022
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries
05:00am, Monday, 25'th Jul 2022 GlobeNewswire Inc.
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotechnology company, today announced its name change (from Plu
HC Wainwright Reiterates On Pluristem After Encouraging Initial Data
05:32pm, Friday, 15'th Jul 2022 Benzinga
Yesterday Pluristem Therapeutics Inc (NASDAQ: PSTI) announced top-line results from its Phase 3 trial evaluating PLX-PAD in 240 patients for muscle recovery following hip fracture surgery.
HC wain
Pluristem (PSTI) Phase III Study Misses Goal, Stock Down
03:15pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Pluristem (PSTI) phase III study of muscle regeneration following hip fracture surgery evaluating PLX-PAD cells did not meet the primary endpoint. Consequently, the stock declines.
Pluristem (PSTI) Phase III Study Misses Goal, Stock Down
12:24pm, Thursday, 14'th Jul 2022
Pluristem (PSTI) phase III study of muscle regeneration following hip fracture surgery evaluating PLX-PAD cells did not meet the primary endpoint. Consequently, the stock declines.
Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery
10:00am, Wednesday, 13'th Jul 2022 GlobeNewswire Inc.
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://plu
Pluristem Posts Mixed Results From Study Of Muscle Regeneration After Hip Fracture Surgery
09:59am, Wednesday, 13'th Jul 2022
Pluristem Therapeutics Inc (NASDAQ: PSTI) announced topline results from its Phase 3 study of intramuscular administration of allogeneic PLX-PAD cells for muscle injury following arthroplasty for h
Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership
07:00am, Monday, 28'th Mar 2022 GlobeNewswire Inc.
Closing Bell Ringing Ceremony Will Take Place on Monday, March 28 at 3:45 pm ET at Nasdaq MarketSite in Times Square, New York
Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions
11:30am, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
HAIFA, Israel, March 23, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company developing novel cell therapies, today announced positive f
Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture
12:12pm, Tuesday, 08'th Mar 2022 GlobeNewswire Inc.
HAIFA, Israel, March 08, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company (“Pluristem”), and Tnuva Group (“Tnuva Group” or �
3 Penny Stocks Insiders Are Buying
12:06pm, Tuesday, 15'th Feb 2022 Benzinga
Although Eurozone economy grew 0.3% on quarter during the last three months of 2021, in-line with flash estimates, there were a few notable insider trades.
When insiders purchase or sell shares, it in
Best Penny Stocks to Buy as January Ends? 4 to Watch
04:30pm, Saturday, 22'nd Jan 2022 PennyStocks
Here are four penny stocks to add to your end of January watchlist
The post Best Penny Stocks to Buy as January Ends? 4 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | P
Best Penny Stocks to Buy as January Ends? 4 to Watch
11:30am, Saturday, 22'nd Jan 2022
Here are four penny stocks to add to your end of January watchlist The post Best Penny Stocks to Buy as January Ends? 4 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
PSTI, BLRX and BBIG among pre-market gainers
01:18pm, Tuesday, 18'th Jan 2022 Seeking Alpha
Mainz Biomed (MYNZ) +14%. Vinco Ventures (BBIG) +13%. Digital World Acquisition (DWACW) +11%. Pluristem Therapeutics (PSTI) +10%
Pluristem Therapeutics Inc Shares Close the Day 10.3% Higher - Daily Wrap
12:57pm, Sunday, 16'th Jan 2022 Kwhen Finance
Pluristem Therapeutics Inc (PSTI) shares closed today 10.3% higher than it did at the end of yesterday. The stock is currently up 32.2% year-to-date, down 76.0% over the past 12 months, and down 87.6% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $2.04 and as low as $1.65 this week.Shares closed 77.6% below its 52-week high and 41.9% above its 52-week low.Trading volume this week was 96.1% lower than the 10-day average and 88.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -525.5% The company's stock price performance over the past 12 months lags the peer average by 130.9%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Thinking about buying stock in Pluristem Therapeutics, DiDi Global, Robinhood Markets, Bitfarms, or Adamis Pharmaceuticals?
03:55pm, Monday, 10'th Jan 2022 Benzinga
NEW YORK , Jan. 10, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PSTI, DIDI, HOOD, BITF, and ADMP. Full story available on Benzinga.com